Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.
J Allergy Clin Immunol Pract
; 8(2): 527-539.e9, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31351189
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Asthma
/
Sinusitis
/
Rhinitis
/
Anti-Asthmatic Agents
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol Pract
Year:
2020
Document type:
Article
Country of publication:
United States